Literature DB >> 4127326

Letter: A rational prophylactic therapy for multiple sclerosis?

E J Field.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4127326     DOI： 10.1016/s0140-6736(73)92678-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Non-specificity of laboratory test for diagnosis of multiple sclerosis.

Authors:  J Mertin; D Hughes; E A Caspary; A M Thomson; J B Foster; E G Stewart-Wynne
Journal:  Br Med J       Date:  1974-12-07

2.  [Remarks to the paper of H. Meyer-Rienecker, H.-L. Jenssen, H. Köhler, J. Günther und H. J. Gundlach: Utilization and significance of the macrophages-electrophoresis-mobility (MEM)-test in neurologic diseases].

Authors:  E J Field
Journal:  Klin Wochenschr       Date:  1974-11-15

3.  Letter: Diagnostic test for multiple sclerosis.

Authors:  J B Foster; J Mertin; A M Thomson
Journal:  Br Med J       Date:  1974-03-09

4.  Letter: Effect of viruses on lymphocyte reactivity.

Authors:  E J Field
Journal:  Br Med J       Date:  1974-02-09

5.  [The macrophage electrophoretic mobility LAD test - a diagnostic method for multiple sclerosis.].

Authors:  H Meyer-Rienecker; H L Jenssen; H Köhler; J K Günther
Journal:  J Neurol       Date:  1976-02       Impact factor: 4.849

6.  Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease.

Authors:  E J Field; G Joyce; B M Smith
Journal:  J Neurol       Date:  1977-01-13       Impact factor: 4.849

7.  Anomalous lymphocyte-antigen reaction in relatives of multiple sclerosis patients. A study of a possible genetic factor in the disease.

Authors:  E J Field; H J Meyer-Rienecker; B K Shenton; H L Jenssen; H Köhler
Journal:  J Neurol       Date:  1977-09-12       Impact factor: 4.849
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.